Ironwood Pharmaceuticals to Host First Quarter 2017 Investor Update Call
April 24 2017 - 4:01PM
Business Wire
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it
will host its first quarter 2017 investor update conference call
and webcast at 8:30 a.m. Eastern Time on Monday, May 8, 2017.
Individuals interested in participating in the call should dial
(877) 643-7155 (U.S. and Canada) or (914) 495-8552 (international)
using conference ID number 97298445. To access the webcast, please
visit the Investors section of Ironwood’s website at
www.ironwoodpharma.com at least 15 minutes prior to the start of
the call to ensure adequate time for any software downloads that
may be required.
The call will be available for replay via telephone starting May
8, 2017 at approximately 11:30 a.m. Eastern Time, running through
11:59 p.m. Eastern Time on May 15, 2017. To listen to the replay,
dial (855) 859-2056 (U.S. and Canada) or (404) 537-3406
(international) using conference ID number 97298445. The archived
webcast will be available on Ironwood’s website for 14 days
beginning approximately one hour after the call has completed.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NASDAQ: IRWD) is a commercial
biotechnology company focused on creating medicines that make a
difference for patients, building value for our fellow
shareholders, and empowering our passionate team. We are
commercializing two innovative primary care products: linaclotide,
the U.S. branded prescription market leader for adults
with irritable bowel syndrome with constipation (IBS-C) or chronic
idiopathic constipation (CIC), and lesinurad, which is approved to
be taken with a xanthine oxidase inhibitor (XOI) for the treatment
of hyperuricemia associated with uncontrolled gout. We are also
advancing a pipeline of internally and externally generated
innovative product candidates in areas of significant unmet need,
including uncontrolled gastroesophageal reflux disease and vascular
and fibrotic diseases. Ironwood was founded in 1998 and is
headquartered in Cambridge, Mass. For more information,
please
visit www.ironwoodpharma.com or www.twitter.com/ironwoodpharma;
information that may be important to investors will be routinely
posted in both these locations.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170424006414/en/
Ironwood Pharmaceuticals, Inc.Media RelationsTrista Morrison,
617-374-5095Director, Corporate
Communicationstmorrison@ironwoodpharma.comorInvestor
RelationsMeredith Kaya, 617-374-5082Director, Investor
Relationsmkaya@ironwoodpharma.com
Ironwood Pharmaceuticals (NASDAQ:IRWD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ironwood Pharmaceuticals (NASDAQ:IRWD)
Historical Stock Chart
From Apr 2023 to Apr 2024